Jun 30, 2023

Alkermes Q2 2023 Earnings Report

Alkermes demonstrated strong financial performance in Q2 2023, driven by proprietary product growth and the Janssen arbitration outcome.

Key Takeaways

Alkermes reported strong Q2 2023 financial results, with total revenues of $617.4 million, including $248.4 million from the Janssen arbitration. Net sales of proprietary products increased by 21% year-over-year. The company reiterated its financial expectations for the full year 2023.

Total revenues for the quarter were $617.4 million, compared to $276.2 million for the same period in the prior year.

Net sales of proprietary products increased approximately 21% year-over-year.

GAAP net income was $237.1 million, or $1.38 per diluted share.

The company recorded cash, cash equivalents and total investments of $907.2 million.

Total Revenue
$617M
Previous year: $276M
+123.5%
EPS
$0.55
Previous year: $0.06
+816.7%
Gross Profit
$453M
Previous year: $218M
+108.1%
Cash and Equivalents
$907M
Previous year: $760M
+19.4%
Free Cash Flow
$206M
Previous year: -$12.3M
-1779.2%
Total Assets
$2.19B
Previous year: $1.96B
+11.7%

Alkermes

Alkermes

Alkermes Revenue by Segment

Forward Guidance

Alkermes reiterated its financial expectations for 2023.

Revenue & Expenses

Visualization of income flow from segment revenue to net income